Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07074171 · ClinicalTrials.gov registry record · NA
Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 384
- Enrollment target
NCT07074171: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT07074171 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 384 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07074171, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 384 participants
- Enrollment target
Study Summary
In this Phase III study, the investigators will build off of the Phase II embedded study with some adjustments to the design to address new research priorities that examine an intervention that is network informed and delivered through community health worker interactions plus digitally-delivered intervention content with the goal of increasing COVID-19 testing and vaccination. This model, if proven effective, can be scaled up to address COVID-19 and other future pandemics. The investigators will utilize the sample of intervention priority census block groups (PBGs) used in Phase II and will recruit and enroll participants not previously enrolled in either phase I or II from these PBGs using convenience sampling methods. The investigators will use a historical control group consisting of participants from our control arm in Phase II who completed both their baseline and follow-up surveys embedded in the study.
Primary Outcome
The number of participants who self-reported use of COVID-19 antigen test or PCR Test using individual-level data in the past 60 days
Interventions
- BEHAVIORAL Text message-based education intervention
- OTHER Historical Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 384 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2024-12-12 |
| Phase | NA |
What the finished NCT07074171 record still lists
NCT07074171 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Text message-based education intervention is the first listed.
NCT07074171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07074171 about?
NCT07074171 is a clinical study titled "Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing". In this Phase III study, the investigators will build off of the Phase II embedded study with some adjustments to the design to address new research priorities that examine an intervention that is network informed and delivered through community health worker interactions plus digitally-delivered in...
What is the current status of trial NCT07074171?
This trial is currently completed. It is a NA study. The enrollment target is 384 participants. The study started on 2023-04-03. Estimated completion is 2024-12-12.
What interventions are being tested in trial NCT07074171?
The interventions under investigation include: Text message-based education intervention (BEHAVIORAL), Historical Control (OTHER).
Who is sponsoring clinical trial NCT07074171?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07074171's enrollment target sits among peer trials
384 271st of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
- NCT06566703 · 384 participants · NA
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI